Japan, Nov. 17 -- VERTEX PHARMACEUTICALS INC has got intellectual property rights for 'MODIFIED MEMBRANE TYPE SERINE PROTEASE 1 (MTSP-1) POLYPEPTIDES AND METHODS OF USE.' Other related details are as follows:
Application Number: JP,2024-038624
Category (FI): C12P21/02@C,C12N15/63@Z,C12N15/70@Z,C12N15/74@Z,C12N15/81@Z,C12N15/85@Z,C12N1/15,C07K19/00,A61P43/00,111,A61P37/06,A61P31/00,C12N1/19,C12N1/21,C12N15/13,A61P3/10,C12N15/57,C12N15/62@Z,A61P29/00,101,A61P29/00,C12N15/861@Z,C12N15/863@Z,C12N15/866@Z,C12N15/867@Z,C12N15/869@Z,C12P21/00@C,C12N9/64@Z,C12N5/10,A61P27/02,A61P25/28,A61P25/00,A61P21/04,A61P19/02,A61P13/12,A61P11/06,A61P1/04,A61K48/00,A61K38/48,A61K38/02,A61K35/763,A61K35/761,A61K35/76,C07K16/00,A61P9/10,A61P9/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 13, 2024
Publication Date: July 10, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
